Anika Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $263.6M | $89.0M |
| FY2019 | — | $288.4M | $157.5M |
| FY2020 | — | $272.4M | $95.8M |
| FY2021 | — | $287.1M | $94.4M |
| FY2022 | — | $285.6M | $86.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $263.6M | $89.0M |
| FY2019 | — | $288.4M | $157.5M |
| FY2020 | — | $272.4M | $95.8M |
| FY2021 | — | $287.1M | $94.4M |
| FY2022 | — | $285.6M | $86.3M |